知道什么是BACE,知道你的抑制剂的特异性是很好的
Aoife Murray1, Ana Muñiz-García1, Ivan Alić1,2
1The Blizard Institute, Faculty of Medicine and Dentistry, Queen Mary University of London, London, United Kingdom.
研究人员确定可溶性VEGFR3 (sVEGFR3) 作为BACE2活性的特定标志物. 这一发现有助于监测阿尔茨海默病 (AD) 药物副作用,特别是不必要的BACE2.2抑制.
科学领域:
- 神经科学是一个神经科学.
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
背景情况:
- 粉样β- (Aβ) 的产生,聚合和清除是阿尔茨海默氏症 (AD) 病原体的核心.
- 在AD治疗中抑制β位APP裂变酶1 (BACE1) 已失败.
- BACE1 抑制剂经常交叉抑制 BACE2,其抑制可能抵消AD治疗.
研究的目的:
- 为了在体内确定BACE2活性的特定药理动力学标志物.
- 为了在BACE1向的AD治疗期间监测不必要的BACE2抑制.
主要方法:
- 利用遗传学和大脑器官模拟研究.
- 研究了BACE1和BACE2的抑制作用.
- 确定并验证了一种新的血生物标志物.
主要成果:
- 溶性VEGFR3 (sVEGFR3) 被确定为BACE2裂变的特定药理动力学标志物.
- sVEGFR3水平反映了独立于BACE1活动的BACE2活动.
- 这种标记物可以通过血获得.
结论:
- sVEGFR3作为可靠的血生物标志物,用于在体内监测BACE2活性.
- 这一发现有助于评估BACE1抑制剂对BACE2交叉抑制的安全性.
- 通过监测酶活性,为阿尔茨海默病提供更好的治疗策略.
更多相关视频
07:42Deferred Growth Inhibition Assay to Quantify the Effect of Bacteria-derived Antimicrobials on Competition
Published on: September 3, 2016
10:24NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases
Published on: June 30, 2019
相关概念视频
Enzyme Inhibition
Dose-Response Relationship: Selectivity and Specificity
Enzymes
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Indirect-Acting Cholinergic Agonists: Mechanism of Action
Reversible inhibitors like edrophonium bind to a specific part of the enzyme called the anionic catalytic site. They form noncovalent bonds, which means they are not strongly attached to the enzyme. This creates a temporary and less stable enzyme–inhibitor complex,...
Targets for Drug Action: Overview
Receptors are either membrane-spanning or intracellular proteins, which upon binding a ligand, get activated and transmit the signal downstream to elicit a response. Drugs bind receptors, either mimicking the action of endogenous ligands or blocking the receptor activity to bring about a modified response. Nearly 35% of approved drugs target the G...
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
